Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Viridiana Cano Garcia
Observed name:
Viridiana Cano García
Institution:
Swedish Orphan Biovitrum (Sweden)
Observed institutions:
University of Southern California,
Children's Hospital Los Angeles,
Sanofi (United States),
Swedish Orphan Biovitrum (Sweden)
ORCID:
0000-0002-3795-4137
Observed ORCID:
0000-0002-3795-4137
OpenAlex ID:
A5070156690
Thromboelastography and thrombin generation assay in inherited afibrinogenemia
2018
·
Guy Aaron Young
, Roxana Carmona
, et al.
·
Haemophilia
·
19
Patient and caregiver preferences for haemophilia treatments: A discrete‐choice experiment
2024
·
Viridiana Cano Garcia
, Carol Mansfield
, et al.
·
Haemophilia
·
8
Development of a Quantitative Systems Pharmacology Model to Explore Hemostatic Equivalency of Antithrombin Lowering
2022
·
Chanchala Kaddi
, Mengdi Tao
, et al.
·
Blood
·
4
Use of Avatrombopag in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 Adopt Study
2024
·
María Eva Mingot-Castellano
, María Teresa Alvarez-Román
, et al.
·
Blood
·
2
PDF
Low risk for meningococcal and other encapsulated bacteria infections with systemically administered pegcetacoplan in paroxysmal nocturnal hemoglobinuria and C3 glomerulopathies
2025
·
Carlos de Castro
, Viridiana Cano Garcia
, et al.
·
Blood
PDF
Patient-reported outcomes of avatrombopag for chronic immune thrombocytopenia: Interim analysis of the Phase 4 adopt study
2025
·
Maria Eva Mingot
, María Teresa Alvarez-Román
, et al.
·
Blood
PDF
Overview of treatment advances with complement inhibitors in patients with paroxysmal nocturnal hemoglobinuria
2025
·
Carlos de Castro
, Peter Hillmen
, et al.
·
Blood
PDF
Experiencia de 13 años en el Instituto Nacional de Pediatría en pacientes con leucemia aguda linfoblástica mayores de 10 años de edad al momento del diagnóstico
2019
·
Viridiana Cano García
Show more works
View as search
Works count:
8
Citation count:
33
H-index:
3
I10-index:
1
Year
Topic
Type
